Calidi Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.59	1.95	0.37	2.14	0.42
Cash & Short-Term Investments	9.59	1.95	0.37	2.14	0.42
Cash Growth	392.10%	423.93%	-82.59%	408.81%	-
Prepaid Expenses	0.54	2.25	0.31	0.5	0.09
Restricted Cash	0.1	0.1	0.1	0.1	-
Total Current Assets	10.23	4.3	0.79	2.74	0.51
Property, Plant & Equipment	3.8	5.34	1.09	0.59	0.72
Long-Term Deferred Charges	-	-	-	-	0.62
Other Long-Term Assets	0.15	0.37	0.73	0.07	-
Total Assets	14.18	10.02	2.6	3.39	1.85
Accounts Payable	2.07	2.88	2.27	0.62	0.97
Accrued Expenses	2.98	5.43	5.35	3.51	1.54
Short-Term Debt	0.47	0.53	3.46	5	4.94
Current Portion of Long-Term Debt	2.7	0.28	1.96	-	-
Current Portion of Leases	1.27	1.12	0.12	0.14	0.34
Other Current Liabilities	-	-	29.83	16.69	1.1
Total Current Liabilities	9.5	10.23	42.99	25.96	8.89
Long-Term Debt	0.6	2.06	-	-	6.37
Long-Term Leases	1.99	3.25	0.45	0.04	0.07
Other Long-Term Liabilities	0.13	2.71	-	-	-
Total Liabilities	12.21	18.25	43.44	26	15.33
Common Stock	0	0	0	0	0
Additional Paid-In Capital	123.28	91.38	19.93	13.32	11.95
Retained Earnings	-121.72	-99.57	-70.36	-44.93	-34.44
Comprehensive Income & Other	-0.03	-0.05	-0.01	-0	0.01
Total Common Equity	1.53	-8.24	-50.44	-31.61	-22.48
Minority Interest	0.43	-	-	-	-
Shareholders' Equity	1.97	-8.24	-40.84	-22.61	-13.48
Total Liabilities & Equity	14.18	10.02	2.6	3.39	1.85
Total Debt	7.04	7.24	5.99	5.18	11.72
Net Cash (Debt)	2.56	-5.29	-5.62	-3.04	-11.3
Net Cash Per Share	0.32	-3.14	-6.60	-1.54	-6.60
Filing Date Shares Outstanding	30.27	3.55	20.62	19.93	1.71
Total Common Shares Outstanding	22.56	3.55	20.62	19.93	1.71
Working Capital	0.73	-5.93	-42.2	-23.22	-8.38
Book Value Per Share	0.07	-2.32	-2.45	-1.59	-13.12
Tangible Book Value	1.53	-8.24	-50.44	-31.61	-22.48
Tangible Book Value Per Share	0.07	-2.32	-2.45	-1.59	-13.12
Machinery	1.64	1.66	1.1	0.68	0.46

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q